March 26 Product: Mercks Winrevair Indication: Pulmonary arterial hypertension People with pulmonary arterial hypertension (PAH) now have a therapy that targets the root of their disease after the FDA approved Mercks Winrevair on Tuesday
If youre starting a GLP-1 medication, or supporting someone who is, the question that comes up almost immediately is practical: what does a GLP-1 diet actually look like day to day
GLP-1R = appetite suppression
Subscribe biotechnology, chronic disease, CMS, Donald Trump, Drug prices, Medicaid, Medicare, Medicare negotiation, Obesity, Pharmaceuticals, Policy, STAT+ Daniel covers the intersection of the health industry and the federal government
In contrast, aging rats with FC showed damaged villi, increased intercellular space, reduced goblet cells, and multiple inflammatory nodules